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Abstract
Introduction The optimal bowel preparation strategy
to minimise the risk of anastomotic leak is yet to be
determined. This study aimed to determine whether
oral antibiotics combined with mechanical bowel prepa-
ration (MBP+Abx) was associated with a reduced risk of
anastomotic leak when compared to mechanical bowel
preparation alone (MBP) or no bowel preparation
(NBP).
Methods A pre-planned analysis of the European Society
of Coloproctology (ESCP) 2017 Left Sided Colorectal
Resection audit was performed. Patients undergoing elec-
tive left sided colonic or rectal resection with primary
anastomosis between 1 January 2017 and 15 March
2017 by any operative approach were included. The pri-
mary outcome measure was anastomotic leak.
Results Of 3676 patients across 343 centres in 47
countries, 618 (16.8%) received MBP+ABx, 1945 MBP
(52.9%) and 1099 patients NBP (29.9%). Patients
undergoing MBP+ABx had the lowest overall rate of
anastomotic leak (6.1%, 9.2%, 8.7% respectively) in
unadjusted analysis. After case-mix adjustment using a
mixed-effects multivariable regression model, MBP+Abx
was associated with a lower risk of anastomotic leak
(OR 0.52, 0.30–0.92, P = 0.02) but MBP was not
(OR 0.92, 0.63–1.36, P = 0.69) compared to NBP.
Conclusion This non-randomised study adds ‘real-
world’, contemporaneous, and prospective evidence of
the beneficial effects of combined mechanical bowel
preparation and oral antibiotics in the prevention of
anastomotic leak following left sided colorectal resection
across diverse settings. We have also demonstrated lim-
ited uptake of this strategy in current international col-
orectal practice.
Keywords Colorectal surgery, colonic cancer, laparo-
scopic surgery, bowel preparation, anastomotic leak
What does this paper add to the literature?
This international study found that administration of
combined oral antibiotics with mechanical bowel prepa-
ration halved the odds of anastomotic leak following left
sided colorectal surgery compared to those with no
bowel preparation; a finding consistent across sensitivity
analyses. Despite this, only 16.8% of patients received
this preparation strategy in contemporary practice.
Introduction
Anastomotic leak following left sided colorectal surgery
is associated with increased morbidity and mortality,
reduced quality of life and worse oncological outcomes
[1,2]. As such, identifying perioperative measures that
may reduce anastomotic failure rates is a major research
focus.
The optimal preoperative bowel preparation regime
in left sided colorectal surgery remains controversial.
Current enhanced recovery after surgery (ERAS) recom-
mendations states that mechanical bowel preparation
(MBP) should not be used routinely in colonic surgery
due to the distressing adverse effects that can be associ-
ated [3] with lack of evidence for benefit [4,5]. The
majority of data on combined MBP with selective gas-
trointestinal decontamination with oral antibiotics
Correspondence to: Mr James Glasbey, European Society of Coloproctology
(ESCP) Cohort Studies Committee, Department of Colorectal Surgery,
University of Birmingham, Heritage Building, Mindelsohn Way, Birmingham
B15 2TH, UK.
E-mail: j.glasbey@bham.ac.uk
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32 15
Original article doi:10.1111/codi.14362
comes from retrospective analyses of large North Ameri-
can databases. These demonstrate evidence of reduction
in anastomotic leak and surgical site infection rates
when compared to MBP alone, oral antibiotics alone or
no preparation [6–11]. Evidence from several published
clinical trials is consistent with this finding, but ran-
domised evidence remains of low and moderate
methodological quality with high risk of bias. In Europe
[12], mechanical bowel preparation with concurrent
oral antibiotics is the subject of a number of blinded,
multi-centre randomised trials currently open to recruit-
ment, but in the years before they report there remains
no existing high quality prospective data to support this
choice of preoperative bowel preparation strategy in
elective colectomy [13].
The primary aim of this study was to explore associ-
ations between bowel preparation strategy and anasto-
motic leak after elective left sided colorectal resection
with primary anastomosis. The secondary aims were to
explore associations of anastomotic technique with




This prospective, observational, multi-centre audit
was conducted in line with a pre-specified proto-
col (http://www.escp.eu.com/research/cohort-studies).
An external pilot of the protocol and data capture sys-
tem was conducted in five international centres prior
to launch, allowing refinement of the study tool and
delivery. This data was not included within the main
study analysis.
Centre eligibility
Any unit performing gastrointestinal surgery was eligible
to register to enter patients into the study. No mini-
mum case volume, or centre-specific limitations were
applied. The study protocol was disseminated to regis-
tered members European Society of Coloproctology
(ESCP), and through national surgical or colorectal
societies.
Patient eligibility
Adult patients (> 16 years) undergoing planned, elec-
tive left hemicolectomy, sigmoid colectomy or rectal
resection with a single, primary anastomosis were
extracted from the main audit database. Operations
with multiple (> 1) anastomoses were excluded as were
resections with formation of end colostomy without
restoration of gastrointestinal continuity (e.g.
abdominoperineal resection, Hartmann’s procedure),
more extensive colorectal resection (e.g. subtotal or
total colectomy),, pouch formation, pelvic exenteration
or multivisceral resection and reversal of colostomy.
Both malignant and benign indications for surgery were
eligible. Open, laparoscopic, laparoscopic-converted,
robotic and robotic-converted procedures were all eligi-
ble, including those incorporating a perineal approach,
both traditional or transanal.
Data capture
Consecutive sampling was performed of eligible patients
over an 8-week study period in each included centres.
Local investigators commenced data collection on any
date between the 1 January 2017 and 15 March 2017,
with the last eligible patient being enrolled on 10 May
2017. This study adopted the UK National Research
Collaborative model for data collection and follow-up.
Small teams of up to five surgeons or surgical trainees
worked together to collect prospective data on all eligible
patients at each centre. Quality assurance was provided
by at least one consultant or attending-level surgeon.
Data was recorded contemporaneously and stored on a
secure, user-encrypted online platform (REDCap) with-
out using patient identifiable information. Centres were
asked to validate that all eligible patients during the study
period had been entered, and to attain > 95% complete-
ness of data field entry prior to final submission.
There were three main phases of data collection for
each patient, each represented by separate clinical
reporting forms. Case report form (CRF) A collected
baseline patient- and disease-specific characteristics
including Age, Gender, American Society of Anaesthesi-
ologists (ASA) classification grade, smoking history,
body mass index, history of diabetes mellitus, cardiovas-
cular disease, concurrent anticoagulant therapy, indica-
tion for surgery, disease location and urgency of
surgery. CRF B collected information about the index
operation and non-patient or disease related factors
including operator grade (Consultant, Trainee), opera-
tor specialty interest (Colorectal, General Surgery),
operative approach, level of proximal and distal transec-
tion, anastomosis type (handsewn, stapled), anastomotic
configuration (side-to-side, side-to-end, end-to-end),
distance of the anastomosis from the anal verge (in cen-
timetres), whether an intraoperative leak test was per-
formed, and whether a proximal defunctioning
enterostomy (loop ileostomy, end ileostomy, loop
colostomy) was formed.
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Case report form C collected follow-up data on the
primary and secondary outcome measures. This study
was designed to bring efficiency by using normal post-
operative follow-up pathways to obtain outcome data.
Follow-up data was collected to 30 postoperative days
through review of patient notes (paper and electronic)
during their index admission, reviewing hospital systems
to check for readmission or reoperation, and reviewing
postoperative radiology reports. Where postoperative
review at or before 30 postoperative days formed part
of routine practice follow-up data was also obtained at
this clinical review.
Outcome measure
The primary outcome measure was overall anasto-
motic leak, pre-defined as either (i) gross anastomotic
leakage proven radiologically or clinically, or (ii) the
presence of an intraperitoneal (abdominal or pelvic)
fluid collection on post-operative imaging. The sec-
ondary outcome measures were the postoperative
major complication rate, defined as Clavien-Dindo
classification grade 3 to 5 (reoperation, reintervention,
unplanned admission to critical care, organ support
requirement or death), the postoperative length of
stay (in whole days), with day of surgery as day zero,
and the postoperative mortality rate, defined as death
within 30 days of surgery.
Statistical analysis
This report has been prepared in accordance to guideli-
nes set by the STROBE (strengthening the reporting of
observational studies in epidemiology) statement for
observational studies [14].
Patient, disease and operative characteristics were com-
pared by type of bowel preparation (no bowel preparation
(NBP), mechanical bowel preparation alone (MBP),
mechanical bowel preparation and oral antibiotics (MBP +
Abx) and by the primary outcome anastomotic leak using
Student’s t-test for normal, continuous data, Mann–Whit-
ney U test for non-normal continuous data or Chi-squared
test for categorical data. To test the association between
overall anastomotic leak and the main explanatory variables
of interest (type of bowel preparation, other non-patient
and disease related factors described above), a mixed-effects
logistic regression model was fitted. Clinically plausible
patient, disease and operation-specific factors were entered
into the model for risk-adjustment, treated as fixed effects.
These were defined a priori within the study protocol, and
included irrespective of their significance on univariate anal-
ysis. Hospitals were entered into the model as a random-
Data cleaning
Cohort selection
Records uploaded to the ESCP 
REDCap database (n=5788)
Excluded from analysis (n=147)
•  Patients <16 years (n=2)
•  Missing anastomosis type (n=49)
•  Missing anastomotic leak outcome (n= 65)
•  Missing complication outcome (n=31)
Primary restorative anastomosis formed (n=3676)
Patients undergoing elective surgery 
(n=4487)
Excluded from analysis (n=811)
•  Patients without anastomosis (n=811)
Excluded from analysis (n=1154)
•  Emergency surgery (less than 24h) (n=591)
•  Expedited surgery (less than 2 weeks)
Anastomosis type
Eligible and completed records (n=5641)
Enrollment
Included in analysis
Figure 1 Flowchart for patients included in analysis of bowel preparation and intraoperative factors in elective left colorectal
resection.
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Table 1 Patient and disease characteristics of patients by bowel preparation strategy.
Factor Levels No bowel prep MBP only
MBP and
pre-op oral ABx P-value
Age < 55 254 (23.1) 371 (19.1) 115 (18.6) 0.002
55–70 451 (41.0) 887 (45.6) 265 (42.9)
70–80 296 (26.9) 516 (26.5) 170 (27.5)
> 80 98 (8.9) 171 (8.8) 65 (10.5)
Missing 0 (0.0) 0 (0.0) 3 (0.5)
Gender Female 493 (44.9) 784 (40.3) 242 (39.2) 0.029
Male 606 (55.1) 1161 (59.7) 376 (60.8)
ASA class Missing 0 (0.0) 5 (0.3) 24 (3.9) < 0.001
Low risk (ASA 1–2) 828 (75.3) 1288 (66.2) 434 (70.2)
High risk (ASA 3–5) 271 (24.7) 652 (33.5) 160 (25.9)
BMI Normal weight 361 (32.8) 552 (28.4) 193 (31.2) < 0.001
Underweight 33 (3.0) 37 (1.9) 13 (2.1)
Overweight 443 (40.3) 837 (43.0) 262 (42.4)
Obese 241 (21.9) 497 (25.6) 113 (18.3)
Missing 21 (1.9) 22 (1.1) 37 (6.0)
History of
IHD/CVA
Missing 1 (0.1) 0 (0.0) 1 (0.2) 0.009
No 960 (87.4) 1619 (83.2) 542 (87.7)
Yes 138 (12.6) 326 (16.8) 75 (12.1)
History of diabetes
mellitus
Missing 1 (0.1) 0 (0.0) 2 (0.3) 0.038
No 969 (88.2) 1651 (84.9) 533 (86.2)
Diabetes: any
control
129 (11.7) 294 (15.1) 83 (13.4)
Smoking history Non-smoker 893 (81.3) 1669 (85.8) 527 (85.3) 0.017
Current 200 (18.2) 260 (13.4) 84 (13.6)
Missing 6 (0.5) 16 (0.8) 7 (1.1)
Indication Benign 335 (30.5) 321 (16.5) 124 (20.1) < 0.001
Malignant 764 (69.5) 1624 (83.5) 494 (79.9)
Anastomosis
height
Missing 5 (0.5) 2 (0.1) 0 (0.0) < 0.001
Left colon 159 (14.5) 175 (9.0) 76 (12.3)
Sigmoid colon 350 (31.8) 394 (20.3) 157 (25.4)
High rectum 318 (28.9) 417 (21.4) 134 (21.7)
Mid rectum 150 (13.6) 412 (21.2) 124 (20.1)
Low rectum 117 (10.6) 545 (28.0) 127 (20.6)
APER 0 (0.0) 0 (0.0) 0 (0.0)
For malignant disease (n = 2888)
Neoadjuvant therapy Missing 11 (1.0) 5 (0.3) 4 (0.6) < 0.001
Chemotherapy only 29 (2.6) 51 (2.6) 18 (2.9)
Long course CRTx 40 (3.6) 298 (15.3) 97 (15.7)
Short course
radiotherapy
7 (0.6) 75 (3.9) 17 (2.8)
None 674 (61.3) 1193 (61.3) 357 (57.8)
Pre-treatment
T stage
Missing 48 (4.4) 31 (1.6) 28 (4.5) < 0.001
T1 92 (8.4) 159 (8.2) 62 (10.0)
T2 150 (13.6) 432 (22.2) 102 (16.5)
T3 359 (32.7) 806 (41.4) 226 (36.6)
T4 112 (10.2) 194 (10.0) 75 (12.1)
P-value derived from v2 test for categorical variables. % shown by column. NBP, no bowel preparation; MBP, mechanical bowel
preparation only; MBP+ABx, mechanical bowel preparation and oral antibiotics; SD, standard deviation; IQR, interquartile range;
IHD, ischemic heart disease; CVA, cerebrovascular accident; N/A, not applicable.
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effect, to adjust for hospital-level variation in outcome.
Sensitivity analyses were performed for proven anastomotic
leakage only. Effect estimates are presented as odds ratios
(OR) with 95% confidence intervals (95% CI) and two-
tailed P-values. An alpha level of 0.05 was used through-
out. Data analysis was undertaken using R Studio V3.1.1
(R Foundation, Boston, USA).
Ethical approval
All participating centres were responsible for compliance
to local approval requirements for ethics approval or
indemnity as required. In the UK, the National Research
Ethics Service tool recommended that this project was
not classified as research, and the protocol was registered
as clinical audit in all participating centres.
Results
Patient and disease characteristics
This analysis included 3676 patients from 343 centres
in 47 countries (Figure 1). The mean age of included
patients was 66 years (range 18–99 years), 58.4%
(2149/3676) were male, and the majority were low
preoperative risk (69.5% ASA 1–2, 2558/3676).
Resection involved colon only in 35.8% (1317/3676)
and the rectum in 64.2% (2359/3676). The primary
indication for surgery was malignant disease in 78.7%
(2894/3676) and benign disease in 21.3% (782/
3676). The abdominal approach was laparoscopic in
56.2% (2065/3676), robotic in 3.9% (144/3676),
and a transanal perineal approach was used in 10.0%
(369/3676). Pre-operatively, 15.1% (556/3676) of
included patients were on enteral and 0.8% (29/
3676) on parenteral nutritional supplementation. An
intra-abdominal abscess was present preoperatively in
3.0% (111/3676). Few patients were on exogenous
steroid therapy at the time of surgery (10/3676).
Amongst those with a malignant indication for sur-
gery 21.9% (634/2894) had undergone neoadjuvant
therapy, with long-course chemoradiotherapy being
most common strategy (437/634, 66.7%). The major-
ity of oncological resections were for T2 and T3
disease (686/2894, 23.7%; 1399/2894, 48.3% respec-
tively).
Practice of bowel preparation and use of preoperative
antibiotics
Overall 1099 patients received no bowel preparation
(29.9%), 1945 received MBP (52.9%) and 618 (16.8%)
received MBP+ABx. Information on type of bowel
preparation was not obtained in 14 patients. The
patient and disease characteristics of included patients,
grouped by choice of preparation strategy, is shown in
Table 1. Compared to those received MBP alone,
patients undergoing MBP+ABx were older, lower risk,
less likely to be obese, and less likely to have a history
of cardiovascular disease in comparison to those receiv-
ing NBP. When compared to those receiving NBP,
those receiving MBP+ABx were less likely to be current
smokers and were more likely to have disease involving
the low or middle rectum (Figure 2).
Figure 2 Choice of bowel preparation strategy by height of anastomosis.
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For all patients (n = 3676)
Total 3364 312 –
Age < 55 672 (20.0) 68 (21.8) 0.499
55–70 1480 (44.0) 130 (41.7)
70–80 901 (26.8) 86 (27.6)
> 80 309 (9.2) 27 (8.7)
Missing 2 (0.1) 1 (0.3)
Gender Female 1443 (42.9) 84 (26.9) < 0.001
Male 1921 (57.1) 228 (73.1)
ASA class Low risk (ASA 1–2) 2348 (69.8) 210 (67.3) 0.584
High risk (ASA 3–5) 988 (29.4) 100 (32.1)
Missing 28 (0.8) 2 (0.6)
BMI Normal weight 1025 (30.5) 87 (27.9) 0.212
Underweight 74 (2.2) 9 (2.9)
Overweight 1416 (42.1) 128 (41.0)
Obese 781 (23.2) 76 (24.4)
Missing 68 (2.0) 12 (3.8)
History of
IHD/CVA
No 2874 (85.4) 260 (83.3) 0.073
Yes 489 (14.5) 51 (16.3)
Missing 1 (0.0) 1 (0.3)
History of diabetes mellitus No 2898 (86.1) 268 (85.9) 0.303
Diabetes: any control 464 (13.8) 43 (13.8)
Missing 2 (0.1) 1 (0.3)
Smoking history Non-smoker 2846 (84.6) 255 (81.7) 0.343
Current 491 (14.6) 55 (17.6)
Missing 27 (0.8) 2 (0.6)
Indication Benign 716 (21.3) 66 (21.2) 0.957
Malignant 2648 (78.7) 246 (78.8)
Anastomosis height Left colon 376 (11.2) 34 (10.9) < 0.001
Sigmoid colon 842 (25.0) 65 (20.8)
High rectum 822 (24.4) 51 (16.3)
Mid rectum 635 (18.9) 52 (16.7)
Low rectum 683 (20.3) 109 (34.9)
Missing 6 (0.2) 1 (0.3)
For malignant disease (n = 2888)
Total 2643 2643 245
Neoadjuvant therapy Chemotherapy only 92 (3.5) 6 (2.4) 0.014
Long course CRTx 388 (14.7) 49 (20.0)
Short course
radiotherapy
83 (0.1) 16 (6.5)
None 2060 (77.9) 173 (70.6)
Missing 20 (0.8) 1 (0.4)
Pre-treatment T stage T1 293 (11.1) 20 (8.2) 0.206
T2 631 (23.9) 55 (22.4)
T3 1262 (47.7) 137 (55.9)
T4 356 (13.5) 27 (11.0)
Missing 101 (3.8) 6 (2.4)
P-value derived from v2 test for categorical variables. % shown by column. SD, standard deviation; IQR, interquartile range; IHD,
ischemic heart disease; CVA, cerebrovascular accident; N/A, not applicable.
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Intraoperative and technical characteristics
Attempted laparoscopy was the most common initial
operative approach (56.2%, 2065/3676), with a conver-
sion rate of 15.9% (328/2065). 39.9% (1467/3676) of
patients underwent open surgery and 3.9% (144/3676)
robotic surgery (of which 16/144, 11.1% underwent
conversion). 86.4% (3177/3676) underwent stapled
anastomosis, of which 93.7% (2977/3177) used a cir-
cular stapler. 13.6% (499/3676) of anastomoses were
handsewn.
Anastomotic leak
The overall anastomotic leak rate was 8.5% (312/3676).
Patient and disease characteristics (Table 2) and intraop-
erative and technical characteristics (Table 3) differed
between groups of patients who did and did not have
anastomotic leak. In the unadjusted analysis, patients
with leak were more likely to be male, have undergone a
low or middle rectal anastomosis, neoadjuvant therapy, a
handsewn anastomosis, a defunctioning ileostomy, or
had a planned admission to critical care from theatre.




Bowel preparation NBP 1003 (29.8) 96 (30.8) 0.077
MBP 1767 (52.5) 178 (57.1)
MBP+Abx 580 (17.2) 38 (12.2)
Missing 14 (0.4) 0 (0.0)
Anastomotic configuration End to end 2525 (75.1) 239 (76.6) 0.364
Side to side 301 (8.9) 19 (6.1)
Side to end 537 (16.0) 54 (17.3)
Missing 1 (0.0) 0 (0.0)
Anastomotic technique Handsewn 445 (13.2) 54 (17.3) 0.044
Stapled 2919 (86.8) 258 (82.7)
Stapler Type Circular stapler 2734 (81.3) 243 (77.9) 0.224
Linear stapler 182 (5.4) 15 (4.8)
No stapled anastomosis 445 (13.2) 54 (17.3)
Missing 3 (0.1) 0 (0.0)
Leak test performed No 1184 (35.2) 110 (35.3) 0.689
Yes 2172 (64.6) 202 (64.7)
Missing 8 (0.2) 0 (0.0)
Defunctioning stoma Yes 866 (25.7) 116 (37.2) < 0.001
No 2496 (74.2) 196 (62.8)
Missing 2 (0.1) 0 (0.0)
Approach Laparoscopic 1910 (56.8) 155 (49.7) 0.054
Open 1324 (39.4) 143 (45.8)
Robotic 130 (3.9) 14 (4.5)
Missing 0 (0.0) 0 (0.0)
Operator specialty Colorectal 2733 (81.2) 259 (83.0) 0.662
General surgery 628 (18.7) 53 (17.0)
Missing 3 (0.1) 0 (0.0)
Operator training grade Consultant 3097 (92.1) 292 (93.6) 0.573
Trainee 264 (7.8) 20 (6.4)
Missing 3 (0.1) 0 (0.0)
Critical care admission None 2449 (72.8) 172 (55.1)
Planned from theatre 872 (25.9) 102 (32.7)
Unplanned from theatre 20 (0.6) 14 (4.5)
Missing 3 (0.1) 0 (0.0)
P-value derived from Chi2 test for categorical variables. % shown by column. NBP, no bowel preparation; MBP, mechanical bowel
preparation only; MBP+ABx, mechanical bowel preparation and oral antibiotics; SD, standard deviation; IQR, interquartile range;
IHD, ischemic heart disease; CVA, cerebrovascular accident; N/A, not applicable.
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Outcomes of patients by bowel preparation strategy
In the unadjusted analysis (Table 4), the rate of anasto-
motic leak was 6.1% (38/618) in those with MBP+ABx,
9.2% (178/1945) in those with MBP and 8.7% (96/
1099) in those with NBP. Correspondingly, the major
complication rates in those with MBP+Abx was lower
than in the other two groups (8.6%; 11.5%; 11.5%
respectively). The mean length of stay was significantly
higher in those with MBP alone (7.8 days; 8.9 days;
7.8 days respectively, P < 0.001).
In the univariate analysis, no significant association
was seen between choice of bowel preparation strategy
and anastomotic leak (Table 5). Male gender (OR 1.89,
1.37–2.62; P < 0.001) and a low rectal anastomosis
(OR 2.37, 1.19–5.42; P = 0.02) carried an increased
risk of anastomotic failure. Side-to-side configuration
(OR 0.39, 0.15–0.81; P = 0.02), stapled anastomosis
(OR 0.65, 0.44–1.01; P = 0.04), and not having a
defunctioning stoma (OR 0.56, 0.42–0.76; P < 0.001)
conveyed a statistically significant benefit.
In the multilevel model (Figure 3), MBP+Abx was
the only bowel preparation strategy associated with
lower risk of anastomotic failure (OR 0.52, 0.30–
0.92, P = 0.02) than NBP (reference). This associa-
tion was consistent in a sensitivity analysis for ‘pro-
ven’ anastomotic leak alone (Table 6, OR 0.48,
0.26–0.89, P = 0.02). Male gender remained signifi-
cantly associated with a higher rate of anastomotic
leak, and middle age and side-to-side anastomosis a
lower rate of anastomotic leak. The model had
acceptable discrimination (AUC: 0.69).
Clinical impact of anastomotic leak
Patients with anastomotic leak were five times more
likely to die postoperatively than those without
(Table 7, 0.5% versus 3.5%, P < 0.001). Anastomotic
leak was also associated with double the postoperative
length of stay (17.2 days versus 7.9 days, P < 0.001).
The definition of anastomotic leakage chosen as the pri-
mary outcome of this study included the presence of an
intraperitoneal (abdominal or pelvic) fluid collection on
post-operative imaging as well as those leaks ‘proven’
on radiological or clinical examination. Despite giving a
rate nearly double that of the ‘proven’ leaks alone, the
impact on mortality rates and length of stay was
remarkably similar when the two groups are compared.
Discussion
This analysis of a large, multicentre prospective audit of
elective left colorectal resections demonstrated a benefit
for mechanical bowel preparation with oral antibiotics in
the reduction of anastomotic failure, which was consis-
tent across sensitivity analyses. The overall rate of usage
of this bowel preparation strategy remained low, at less
than one-fifth of the international cohort. Anastomotic
leak was associated with worse short-term survival, more
critical care usage and a prolonged length of stay.
This study adds to a growing body of evidence to
support the addition of oral antibiotics to mechanical
bowel preparation regimes for left sided colorectal sur-
gery. A comprehensive systematic review published in
2018 described six randomised controlled trials testing
MBP+ABx, failing to find a benefit upon meta-analysis
[15,16]. However, half of included studies (three of
six) were of unclear methodological quality and pub-
lished more than 20 years ago. Anastomotic outcomes
from these studies are unlikely to be comparable to
those in a modern era of minimally invasive surgery and
modernised stapling devices and thus may lack relevance
to current clinical practice. Of the more contemporary
randomised studies, all three were single-centre and of
Table 4 Outcomes of patients undergoing different types of bowel preparation strategy.
Outcome Levels
Bowel preparation strategy
P valueNBP MBP only MBP+ABx
Leak No leak 1003 (91.3) 1767 (90.8) 580 (93.9) 0.077
Leak 96 (8.7) 178 (9.2) 38 (6.1)
Post-operative complication No major complication 973 (88.5) 1722 (88.5) 565 (91.4) 0.106
Major complication 126 (11.5) 223 (11.5) 53 (8.6)
Length of stay Mean (SD) 7.9 (5.6) 8.9 (5.4) 7.8 (5.1) < 0.001
Post-operative mortality No 1091 (99.3) 1935 (99.5) 615 (99.5) 0.862
Yes 8 (0.7) 10 (0.5) 3 (0.5)
P-values derived from v2 test for categorical variables and Student’s T-test for parametric continuous variables, % shown by column.
NBP, no bowel preparation; MBP, mechanical bowel preparation only; MBP+ABx, mechanical bowel preparation and oral
antibiotics.
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Table 5 Univariable and multilevel models for overall anastomotic leak (primary outcome measure).
Factor Levels
Overall anastomotic leak
OR (univariable) OR (multilevel)No leak Leak
Bowel preparation NBP 547 (25.2) 47 (23.9) Reference Reference
MBP 1260 (58.1) 130 (66.0) 1.20 (0.85–1.72, P = 0.303) 0.92 (0.63–1.36, P = 0.688)
MBP+ABx 360 (16.6) 20 (10.2) 0.65 (0.37–1.09, P = 0.113) 0.52 (0.30–0.92, P = 0.024)
Age < 55 448 (20.7) 54 (27.4) Reference Reference
55–70 960 (44.3) 81 (41.1) 0.70 (0.49–1.01, P = 0.054) 0.64 (0.43–0.95, P = 0.025)
70–80 589 (27.2) 49 (24.9) 0.69 (0.46–1.04, P = 0.073) 0.59 (0.38–0.94, P = 0.025)
> 80 170 (7.8) 13 (6.6) 0.63 (0.32–1.16, P = 0.157) 0.61 (0.30–1.22, P = 0.159)
Gender Female 915 (42.2) 55 (27.9) Reference Reference
Male 1252 (57.8) 142 (72.1) 1.89 (1.37–2.62, P < 0.001) 1.91 (1.35–2.69, P < 0.001)
ASA class Low risk (ASA 1–2) 1536 (70.9) 137 (69.5) Reference Reference
High risk (ASA 3–5) 631 (29.1) 60 (30.5) 1.07 (0.77–1.46, P = 0.693) 1.04 (0.71–1.52, P = 0.834)
BMI Normal weight 700 (32.3) 64 (32.5) Reference Reference
Underweight 41 (1.9) 7 (3.6) 1.87 (0.74–4.09, P = 0.146) 1.95 (0.81–4.67, P = 0.134)
Overweight 952 (43.9) 84 (42.6) 0.97 (0.69–1.36, P = 0.837) 0.94 (0.66–1.35, P = 0.741)
Obese 474 (21.9) 42 (21.3) 0.97 (0.64–1.45, P = 0.880) 0.93 (0.61–1.44, P = 0.760)
History of
IHD/CVA
No 1858 (85.7) 163 (82.7) Reference Reference
Yes 309 (14.3) 34 (17.3) 1.25 (0.84–1.83, P = 0.253) 1.44 (0.91–2.27, P = 0.119)
History of
diabetes mellitus
No 1874 (86.5) 170 (86.3) Reference Reference
Diabetes: any control 293 (13.5) 27 (13.7) 1.02 (0.65–1.53, P = 0.942) 0.97 (0.62–1.52, P = 0.883)
Smoking history Non-smoker 1853 (85.5) 159 (80.7) Reference Reference
Current 314 (14.5) 38 (19.3) 1.41 (0.96–2.03, P = 0.071) 1.25 (0.84–1.85, P = 0.277)
Indication Benign 379 (17.5) 34 (17.3) Reference Reference
Malignant 1788 (82.5) 163 (82.7) 1.02 (0.70–1.52, P = 0.935) 0.79 (0.51–1.23, P = 0.298)
Approach Laparoscopic 1171 (54.0) 100 (50.8) Reference Reference
Open 895 (41.3) 87 (44.2) 1.14 (0.84–1.54, P = 0.398) 1.16 (0.84–1.61, P = 0.369)
Robotic 101 (4.7) 10 (5.1) 1.16 (0.55–2.19, P = 0.670) 0.86 (0.42–1.77, P = 0.680)
Anastomosis
height
Left colon 126 (5.8) 8 (4.1) Reference Reference
Sigmoid colon 373 (17.2) 24 (12.2) 1.01 (0.46–2.46, P = 0.975) 0.91 (0.38–2.17, P = 0.836)
High rectum 501 (23.1) 32 (16.2) 1.01 (0.47–2.39, P = 0.988) 0.91 (0.39–2.13, P = 0.827)
Mid rectum 543 (25.1) 39 (19.8) 1.13 (0.54–2.66, P = 0.758) 1.07 (0.45–2.52, P = 0.882)
Low rectum 624 (28.8) 94 (47.7) 2.37 (1.19–5.42, P = 0.023) 2.14 (0.91–5.03, P = 0.081)
Anastomotic
configuration
End to end 1594 (73.6) 150 (76.1) Reference Reference
Side to side 165 (7.6) 6 (3.0) 0.39 (0.15–0.81, P = 0.025) 0.38 (0.15–0.94, P = 0.036)
Side to end 408 (18.8) 41 (20.8) 1.07 (0.74–1.52, P = 0.722) 0.96 (0.65–1.42, P = 0.840)
Anastomotic
technique
Handsewn 219 (10.1) 29 (14.7) Reference Reference
Stapled 1948 (89.9) 168 (85.3) 0.65 (0.44–1.01, P = 0.044) 0.72 (0.44–1.18, P = 0.197)
Leak test
performed
No 733 (33.8) 73 (37.1) Reference Reference
Yes 1434 (66.2) 124 (62.9) 0.87 (0.64–1.18, P = 0.360) 1.04 (0.72–1.51, P = 0.832)
Defunctioning
stoma
No 1410 (65.1) 101 (51.3) 0.56 (0.42–0.76, P < 0.001) 0.96 (0.64–1.44, P = 0.841)
Yes 757 (34.9) 96 (48.7) Reference Reference
Operator type Colorectal 1745 (80.5) 161 (81.7) Reference Reference
General surgery 422 (19.5) 36 (18.3) 0.92 (0.63–1.33, P = 0.683) 1.03 (0.68–1.56, P = 0.886)
Training grade Consultant 2016 (93.0) 185 (93.9) Reference Reference
Trainee 151 (7.0) 12 (6.1) 0.87 (0.45–1.52, P = 0.642) 1.05 (0.55–1.98, P = 0.889)
AIC: 1340.3. Area Under the Receiver Operating Curve: 0.69
Overall anastomotic leak was pre-defined as either (i) gross anastomotic leakage proven radiologically or clinically, or (ii) the pres-
ence of an intraperitoneal (abdominal or pelvic) fluid collection on post-operative imaging. Odds ratio (OR) presented with 95%
confidence intervals. % shown by column. SD, standard deviation; IQR, interquartile range; IHD, ischemic heart disease; CVA,
cerebrovascular accident; N/A, not applicable.
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limited methodological rigor [17–19]. The highest
quality of these included just 579 patients, was open-
label, and examined anastomotic leak as a secondary
outcome with no clear outcome definition or assess-
ment criteria stated.
The most convincing current evidence supporting
MBP+Abx is found in retrospective analyses of the large
American College of Surgeons’ National Surgical Qual-
ity Improvement Program (ACS-NSQUIP) database.
Seven analyses of this dataset have been published to
date, including around 147 000 patients [6–11,20].
These share common criticisms including the low fide-
lity of retrospectively collected clerical data, high per-
centages of missing data fields and a high propensity for
selection and reporting bias [6–10]. When meta-analysis
has been performed on these observational datasets a
40% reduction in odds of anastomotic leak has been
described [16].
Figure 3 Forest plot for mixed-effects model demonstrating factors associated with overall anastomotic leak.
Table 6 Univariable and multilevel models for ‘proven’ anastomotic leak only (sensitivity analysis).
Factor Levels
Proven anastomotic leak
OR (univariable) OR (multilevel)No leak Leak
Bowel preparation NBP 554 (25.2) 40 (24.1) Reference Reference
MBP 1279 (58.2) 111 (66.9) 1.20 (0.83–1.77, P = 0.336) 0.94 (0.63–1.42, P = 0.780)
MBP+ABx 365 (16.6) 15 (9.0) 0.57 (0.30–1.02, P = 0.069) 0.48 (0.26–0.89, P = 0.021)
Proven anastomotic leak was defined as gross anastomotic leakage proven radiologically or clinically. Patient, disease and operative
factors included in the model are described in Table 5.
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This analysis represents the first prospective observa-
tional assessment of the relationship of MBP+ABx and
anastomotic leak, demonstrating a significant benefit in
elective left sided colorectal anastomoses, which pre-
vailed after risk adjustment for patient, operation and
disease factors. Few other modifiable intraoperative or
technical characteristics had a significant association
with anastomotic leak in univariate or multilevel mod-
els. Side-to-side anastomotic configuration (common in
left sided colonic, rather than rectal resections) appeared
to convey a benefit in multivariable analysis, which may
reflect other unmeasured confounders, such as technical
ease of the procedure and the number of stapler firings
in circular stapled rectal anastomoses. Whilst this study
was underpowered to detect a difference in the primary
outcome within many of these smaller subgroups, varia-
tion within our data suggests that an optimal technique
for left sided colorectal anastomosis is yet to reach con-
sensus. Whilst a number of acceptable modifications are
likely to exist, standardisation of techniques for anasto-
motic formation may improve outcomes by reducing
unacceptable variation.
The ESCP Left Sided Colorectal Resections 2017
audit used the same combined outcome measure of
radiologically or clinically ‘proven’ anastomotic leak or
intraabdominal collection that has been previous
described in the ESCP 2015 audit of Right Sided
Resections [21]. Again the data demonstrated an
increase in adverse postoperative events (death, length
of stay, critical care requirement) of similar magnitude
for both the combined and ‘proven’ anastomotic leak
groups, validating the use of our primary outcome mea-
sure in left sided disease. We recommend that this com-
bined outcome measure is used in future prospective
randomised and non-randomised studies.
This study presents a multicentre evaluation of bowel
preparation practice and its outcomes using a validated
‘snap-shot’ methodology that combines pragmatism
with high-quality, protocolised data collection per-
formed by frontline teams of clinicians in a multicentre,
international setting [22–28]. Randomised trials are
sometimes criticised for being performed in highly
controlled settings (i.e. explanatory trials), and treat-
ment effects described are not realised when adopted
into widespread clinical practice. This study adds to the
literature by demonstrating that a signal for benefit in
combined oral antibiotics and bowel preparation is also
seen in a ‘real world’ setting. We attempted to minimise
the impact of selection bias on our findings by the
application of mixed-effects models adjusting for the
effects of patient, disease, operative and centre level
variation. However we lack the fidelity in this dataset to
examine in detail specific centre level characteristics
regarding those centres applying MBP+ABx in routine
practice (for example surgical resection volume, avail-
ability of adjuncts to testing anastomotic integrity).
There are also likely to be a number of unmeasured
patient and intraoperative risk factors for anastomotic
leak that we were unable to adjust for with this observa-
tional study.
A large, international randomised trial is needed to
determine whether antibiotics alone are sufficient, or
whether it is the combination with mechanical bowel
preparation that is mechanistic. Although the current
evidence base has been stated as being conclusive,
incomplete penetration into clinical practice as demon-
strated within this study and the relatively weak existing
data mean a major trial is warranted. Further efforts to
explore reasons for the low rate of adoption of com-
bined antibiotics and bowel preparation amongst the
international surgical community will support future
quality improvement efforts.
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Table 7 The clinical impact of anastomotic leak.
Total Length of stay (median, IQR) 30-day mortality (%, n)
No leak 3364 7 (5–9) 0.5% (18)
Anastomotic leak and/or collection* 312 15 (11–26) 3.5% (11)
‘Proven’ anastomotic leak only 166 16 (11–26) 3.6% (6)
*Primary outcome for this study – defined as either or both (i) gross anastomotic leakage proven radiologically or clinically or (ii)
the presence of an intraperitoneal (abdominal or pelvic) fluid collection on post-operative imaging. Proven anastomotic leak
included only gross anastomotic leakage proven radiologically or clinically. % shown by row. SD, standard deviation; n, count.
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Besznyak, A. Bursics, G. Papp, G. Saftics, I. Svastics
(Uzsoki Hospital);
Iceland: E. Valsdottir, J. Atladottir, T. Jonsson, P.
Moller, H. Sigurdsson (University Hospital of Iceland).
India: S. K. Gupta, S. Gupta, N. Kaul, S. Mohan, G.
Sharma (Government Medical College, Jammu, Jammu
and Kashmir, India); R. Wani, N. Chowdri, M. Khan,
A. Mehraj, F. Q. Parray (Sher-i-Kashmir Institute of
Medical Sciences).
Ireland: A. Coveney, J. Burke, J. Deasy, S. El-Masry,
D. McNamara (Beaumont Hospital); M. F. Khan, R.
Cahill, E. Faul, J. Mulsow, C. Shields (Mater Misericor-
diae University Hospital); D. Winter, R. Kennelly, A.
Hanly, M. Ismaiel, S. Martin, D. Ahern, M. Kelly, G.
Bass, R. O’Connell (St. Vincent’s University Hospital,
Dublin); T. Connelly, G. Ahmad, W. Bukhari, F. Cooke
(University Hospital Waterford).
Israel: O. Zmora, R. Gold Deutch, N. Haim, R.
Lavy, A. Moscovici (Assaf Harofe Medical Center); N.
Shussman, R. Gefen, G. Marom, A. Pikarsky, D. Weiss
(Hadassah Hebrew University Medical Center); S. Avi-
tal, N. Hermann, B. Raguan, M. Slavin, I. White (Meir
Medical Center); N. Wasserberg, H. Arieli, N. Gurevich
(RMC, Beilinson Campus); M. R. Freund, S. Dorot, Y.
Edden, G. Halfteck, P. Reissman (Shaare Zedek Medi-
cal Center); Y. Edden, R. Pery (Sheba Medical Center);
H. Tulchinsky, A. Weizman (Sourasky Medical Center).
Italy: F. Agresta, R. Curinga, E. Finotti, G. Savino,
L. A. Verza (Adria Hospital); C. R. Asteria, L. Boccia,
A. Pascariello (ASST - Mantua); N. Tamini, A. Bugatti,
L. Gianotti, M. Totis (Asst-Monza, Ospedale San Ger-
ardo); L. Vincenti, V. Andriola, I. Giannini, E. Trava-
glio (Azienda Ospedaliero Universitaria Consorziale
Policlinico di Bari); R. Balestri, P. Buccianti, N. Roffi,
E. Rossi, L. Urbani (Azienda Ospedaliero Universitaria
Pisana); A. Mellano, A. Cinquegrana (Candiolo Cancer
Institute IRCCS); A. Lauretta, C. Belluco (Chirurgia
Oncologica Generale, IRCCS Centro di Riferimento
Oncologico, Aviano); M. Mistrangelo, M. E. Allaix, S.
Arolfo, M. Morino, V. Testa (Citta della Salute e della
Scienza di Torino); P. Delrio, U. Pace, D. Rega, D.
Scala (Division of Colorectal Surgery, Department of
Abdominal Surgery, Istituto Nazionale Tumori “Fon-
dazione G.Pascale “, IRCCS Naples); G. Gallo, G. Cler-
ico, S. Cornaglia, A. Realis Luc, M. Trompetto
(Department of Colorectal Surgery, S. Rita Clinic); G.
Ugolini, N. Antonacci, S. Fabbri, I. Montroni, D. Zat-
toni (Faenza Hospital); C. D’Urbano, A. Cornelli, M.
Viti (G. Salvini); M. Inama, M. Bacchion, A. Casaril, H.
Impellizzeri, G. Moretto (Hospital Dott. Pederzoli); A.
Spinelli, M. Carvello, G. David, F. Di Candido, M. Sac-
chi (Humanitas Research Hospital); A. Frontali, V.
Ceriani, M. Molteni (IRCCS MultiMedica); R. Rosati,
F. Aleotti, U. Elmore, M. Lemma, A. Vignali (IRCCS
San Raffaele, Department of Gastrointestinal Surgery);
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S. Scabini, G. Casoni Pattacini, A. Luzzi, E. Romairone
(Policlinico San Martino, Genoa); F. Marino, D. Lor-
usso, F. Pezzolla (Dept. of General Surgery, IRCCS
“Saverio de Bellis”, Castellana Grotte (Ba)); F.
Colombo, C. Baldi, D. Foschi, G. Sampietro, L. Sor-
rentino (L. Sacco University Hospital); S. Di Saverio, A.
Birindelli, E. Segalini, D. Spacca (Maggiore Hospital);
G. M. Romano, A. Belli, F. Bianco, S. De franciscis, A.
Falato (Surgical Oncology Istituto Nazionale Tumori
G.Pascale Naples); A. Muratore, P. Marsanic (Ospedale
Agnelli Pinerolo); S. Grimaldi, N. Castaldo, M. G.
Ciolli, P. Picarella, R. Porfidia (Ospedale Convenzion-
ato Villa dei Fiori Acerra); S. Di Saverio, A. Birindelli,
G. Tugnoli (Ospedale Maggiore); A. Bondurri, D.
Cavallo, A. Maffioli, A. Pertusati (Ospedale Sacco Italy);
F. Pulighe, F. Balestra, C. De Nisco, M. Podda (Ospe-
dale San Francesco); E. Opocher, M. Longhi, N. M.
Mariani, N. Maroni, A. Pisani Ceretti (Ospedale San
Paolo); R. Galleano, P. Aonzo, G. Curletti, L. Reggiani
(Ospedale Santa Corona); M. Marconi, L. Del Prete,
M. Oldani, R. Pappalardo, S. Zaccone l (Ospedale Santa
Maria delle Stelle); M. Scatizzi, M. Baraghini, S. Canta-
fio, F. Feroci, I. Giani (Ospedale Santo Stefano, Prato);
R. Tutino, G. Cocorullo, G. Gulotta, L. Licari, G. Sala-
mone (Policlinico ‘P. Giaccone’); P. Sileri, F. Saraceno
(Policlinico Tor Vergata); F. La Torre, P. Chirletti, D.
Coletta, G. De Toma, A. Mingoli (Policlinico Umberto
I ‘Sapienza University’); M. Papandrea, E. De Luca, R.
Sacco, G. Sammarco, G. Vescio (Policlinico Universi-
tario di Catanzaro); V. Tonini, S. Bianchini, M. Cervel-
lera, S. Vaccari (Policlinico universitario Sant’Orsola-
Malpighi, Universita degli Studi di Bologna); N.
Cracco, G. Barugola, E. Bertocchi, R. Rossini, G. Ruffo
(Sacro Cuore Don Calabria Hospital); A. Sartori, N.
Clemente, M. De Luca, A. De Luca, G. Scaffidi (San
Valentino Hospital); L. Lorenzon, G. Balducci, T. Boc-
chetti, M. Ferri, P. Mercantini (Sant’Andrea Hospital);
F. Pata, S. Bauce, A. Benevento, C. Bottini, P. R. Crapa
(Sant’ Antonio Abate Hospital, Gallarate); M. Rubbini,
G. Anania, P. Carcoforo, G. Cavallesco, C. Feo
(University Hospital of Ferrara).
Japan: T. Yamamoto (Yokkaichi Hazu Medical Cen-
tre).
Latvia: A. Sivins, G. Ancans, S. Gerkis, R. Lunis, A.
Pcolkins (Latvia Oncology Center).
Lithuania: D. Venskutonis, S. Bradulskis, E. Dainius,
A. Subocius, J. Vencius (Deparment of General Surgery,
LSMU, Kaunas Clinical Hospital); P. Zeromskas, V.
Eismontas, V. Nutautiene, D. Simcikas, A. Tamosiunas
(Klaipeda University Hospital); S. Svagzdys, T. Latkaus-
kas, P. Lizdenis, Z. Saladzinskas, A. Tamelis (Lithuanian
University of Health Sciences Hospital Kauno Klinikos);
A. Dulskas, J. Kuliavas, N. E. Samalavicius (National
Cancer Institute, Lithuania); T. Poskus, V. Jotautas, S.
Mikalauskas, E. Poskus, K. Strupas (Vilnius University).
Malaysia: A. D. Zakaria, N. N.Lah, M. Wong, W. Z.
Zain, Z. Zakaria (Department of Surgery, School of
Medical Sciences, Universiti Sains Malaysia / Hospital
Universiti Sains Malaysia); L. Mazlan, Z. A. Mohd
Azman, I. Sagap (UKM Medical Centre).
Malta: J. Psaila, P. Andrejevic, C. Cini, S. Ellul, K.
Pace (Mater Dei Hospital). Morocco: M. Ahallat, M.
Hamid, A. Hrora, M. A. Majbar, M. Raiss (Ibn Sina
University Hospital).
Netherlands: E. Westerduin, W. Bemelman, C. Bus-
kens, P. Tanis (Academic Medical Centre); P.C. van der
Sluis, P.H. Davids, A. Pronk, A.H.W. Schiphorst, N.
Smakman (Diakonessenhuis); D. Zimmerman, T.
Koeter, J. Stijns, Y-T. van Loon (Elisabeth TweeSteden
Hospital); M. Vermaas, E. de Graaf, P. Doornebosch,
P. van Hagen, O. van Ruler (Ijsselland Ziekenhuis); B.
Toorenvliet, J. Nonner, I. van den Berg, L. van Steen-
sel, W. Vles (Ikazia); J. Melenhorst, R. Orsini, R. Viss-
chers (Maastricht University Medical Centre); C. Hoff
(Medical Center Leeuwarden); R. Blom, H. Marsman
(Onze Lieve Vrouwe Gasthuis); I. Mulder, H. Cense, S.
de Castro, A. Demirkiran, M. Hunfeld (Rode Kruis
Ziekenhuis Beverwijk); A. van Geloven, J. de Groof, E.
Hendriks, M. Leeuwenburg, N. van Oorschot (Ter-
gooi); F. Wit, C. Rupert, P. Veldman (Tjongerschans
ziekenhuis); M. Keijzers, J. Konsten (VieCuri Medisch
Centrum voor Noord Limburg); F. Den Boer, M. Cor-
ver (Zaans Medical Center); E. G.. Boerma, L. Koolen,
M. Martens, K. Van Wijck (Zuyderland Medical Cen-
ter).
Norway: D. Ignjatovic, R. Breuer, B. Gurpreet, T.
Oresland, T. Tetens Moe (Akershus University Hospi-
tal); A. Nesbakken, I. Flaaten Backe, T-A. Wik (Oslo
University Hospital); K. Radiya, T. Dehli, P. Gjessing,
S. Norderval, K. Woll (University Hospital of North
Norway).
Pakistan: M. Anwer, M. S. Qureshi (JPMC WARD
2); A. U. Qureshi, M. Billah, M. Y. Jawad, A. Raza, N.
Urooj (King Edward Medical University/Mayo Hospi-
tal, Lahore).
People’s Republic of China: X. Wang, L. Li (West
China Hospital in Sichuan University).
Poland: D. Jajtner, B. Gasinski, W. Kabiesz (Beskid-
ian Oncology Center); P. Walega, M. Romaniszyn
(Third Department of General Surgery, Jagiellonian
University Medical College); M. Zawadzki, R. Czar-
necki, Z. Obuszko, M. Rzaca, M. Sitarska (Wojewodzki
Szpital Specjalistyczny).
Portugal: P. Silva, A. Duarte, D. Goncalves, M.
Morais (Centro Hospitalar de S. Jo~ao); N. Rama, J.
Nobre, I. Sales (Centro Hospitalar Leiria, EPE); J.
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Costa Pereira, S. Costa, C. Costa Pereira, C. Insua, I.
Romero (Centro Hospitalar Ta^mega e Sousa); N. Fig-
ueiredo, J. Cunha, H. Domingos, P. Vieira (Champali-
maud Foundation); M. Cunha, M. Americano, E.
Amorim, J. Rachadell (Cirurgia 2 - CHA - Unidade
Portim~ao); J. M. Carvas, I. Armas, P. Fernandes, C.
Pires, R. Reis (Hospital de Braganca); R. Martins, M.
Dos Santos, P. Henriques (Hospital de Faro, Centro
Hospitalar do Algarve); O. Oliveira, M. Duarte, L. Fer-
reira, J. Miranda, N. Vilela (Hospital Distrital de San-
tarem, E.P.E.); J. Corte Real, S. Carlos, M. Frois
Borges, P. Moniz Pereira, J. Sim~oes (Hospital Garcia de
Orta); P. Silva-vaz, V. Bettencourt, A. Gouveia, H.
Perez, R. Rainho (Unidade Local de Saude de Castelo
Branco).
Romania: V. Bintintan, C. Ciuce, G. Dindelegan, R.
Scurtu, R. Seicean (Clinica Chirurgie I); D. Cristian, T.
Burcos, F. Grama, D. M. Mandi, G. Richiteanu (Coltea
Clinical Hospital); A. Miron, V. Calu, O. Enciu, M.
Nadragea, R. Parvuletu (Elias Emergency Hospital); S.
S. Mogoanta, A. Crafciuc, S. Paitici (Emergency County
Hospital of Craiova); I. Negoi, M. Beuran, C. Ciubo-
taru, A. Prodan, M. Vartic (Emergency Hospital of
Bucharest); V. Tomulescu, C. Copaescu (Ponderas Aca-
demic Hospital).
Russia: A. Yanishev, A. Abelevich, A. Kokobelyan,
M. Lebedeva, R. Luzan (FSBEI HE PRMU MOH); A.
Pozdnyakov, D. Cherdancev, D. Mahotin, A. Nesytykh,
V. Samsonyuk (Krasnoyarsk Regional Clinical Hospital);
I. Pravosudov, D. Ivlev, A. Karachun, K. Lebedev, D.
Samsonov (N.N. Petrov National Medical Research
Center of Oncology); R. Aiupov, D. Feoktistov, M.
Garipov, N. Suleymanov, N. Tarasov (Republican
Oncological Centre, Ufa); A. Rasulov, H. Dzhumabaev,
Z. Mamedli (Russian Cancer Research Center); A. Bed-
zhanyan (Russian Research Center of Surgery named
after B.V.Petrovsky); D. Popov, A. Sednev, A. Kli-
menko, A. Semenov, S. Vasilyev (Saint-Petersburg City
Hospital 9); A. Khazov, M. Khanevich, G. Khrykov
(Saint-Petersburg Clinical Oncological Health Center);
S. Katorkin, P. Andreev, A. Chernov, O. Davidova, A.
Zhuravlev (Samara State Medical University); S. Achka-
sov, D. Shakhmatov, Y. Shelygin, O. Sushkov, A. Var-
danyan (State Scientific Centre of Coloproctology); A.
Ilkanich, N. Barbashinov, V. Darvin, S. Onishchenko,
Y. Voronin (Surgut District Hospital).
Serbia: Z. Krivokapic, G. Barisic, I. Dimitrijevic, V.
Markovic, A. Sekulic (Clinic for Digestive Surgery-First
Surgical Clinic, Clinical Center of Serbia, University of
Belgrade, Medical Faculty); G. Stanojevic, B. Brankovic,
M. Nestorovic, V. Pecic, D. Petrovic (Clinic for General
Surgery, Clinical Center Nis); I. Kostic, A. Aleksic, D.
Dabic, B. Maric, V. Perunicic (General Hospital Cacak);
Z. Radovanovic, M. Djuric, D. Lukic, D. Radovanovic
(Oncology Institute of Vojvodina); V. Cuk, V. Cuk, J.
Juloski, M. Kenic, I. Krdzic (Surgical Clinic KBC Zvez-
dara).
Singapore: J. C. Ngu, Y. Y. Ng, N. Teo (Changi
General Hospital).
Slovak Republic: J. Korcek, A. Lazorisak, (Faculty
Hospital Nitra).
Slovenia: M. Rems, S. Ramovs Trampus (General
Hospital Jesenice); A. Tomazic, J. Grosek, J. Kosir, G.
Norcic (University Medical Centre Ljubljana).
Spain: V. Vigorita, N. Caceres, E. Casal, A. Ruano,
I. Trostchansky (Alvaro Cunqueiro Hospital); T. Golda,
A. Galvez Salda~na, E. Kreisler Moreno, J. Lopez Dom-
inguez, M. Vila Tura (Bellvitge University Hospital); F.
Labarga, P. Galvez, V. Maderuelo, C. Suero (Complejo
Asistencial Universitario de Palencia); J. Bargallo, L.
Cayetano, S. Lamas, M. C. Silva (Consorci Sanitari de
Terrassa - Hospital de Terrassa); J. C. Bernal-Sprekel-
sen, R. Gomez, S. Jare~no, A. Rıos, D. Vercher (Consor-
cio Hospital General Universitario); J-M. Garcıa-
Gonzalez, J. Cervera-Aldama, J. Ramos-Prada, M. San-
tamarıa-Olabarrieta (Cruces University Hospital); N.
Borda, J. M. Enrriquez-Navascues, Y. Saralegui (Donos-
tia Universitary Hospital); A. Calero-Lillo, S. Aznar-
Puig, M. A. Lopez-Lara, S. Mu~noz-Collado, J. Val-
verde-Sintas (Fundacio Hospital Esperit Sant); P.
Menendez, C. Leon (Gutierrez Ortega Hospital); N.
Truan, R. Baldonedo, D. Fernandez-Martınez, J. Otero,
L. Solar-Garcıa (Hospital Universitario Central de
Asturias); V. Turrado-Rodriguez, F. de Lacy Oliver, A.
M. Lacy Fortuny, B. Martin Perez, A. M. Otero Pi~neiro
(Hospital Clinic Barcelona); J. Paredes, F. Fernandez,
M. J. Ladra, A. Paulos, D. Prieto (Hospital Clinico
Universitario de Santiago de Compostela); J. P. Beltran
de Heredia, F. Blanco Antona, B. de Andres Asenjo, C.
Ferreras Garcıa, A. Romero de Diego (Hospital Clınico
Universitario de Valladolid); E. Cordoba Diaz de
Laspra, E. Echazarreta Gallego, M. Elia Guedea (Hospi-
tal Clinico Universitario de Zaragoza); D. Escola, S.
Martinez (Hospital Comarcal Alt Penedes); V. Primo
Romaguera, R. Parre~no, L. Pastor, E. Rosell (Hospital
de Denia); R. Lozoya Trujillo, R. Alos Company, M.
D. Ruiz Carmona, A. Solana Bueno (Hospital de
Sagunto); S. Salvans Ruiz, S. Alonso Goncalves, M.
Jimenez- Toscano, M. Pascual Damieta, M. Pera
Roman (Hospital Del Mar); E. M. Pellicer-Franco, J. A.
Garcia-Marin, M. Mengual-Ballester, V. Soria-Aledo, G.
Valero-Navarro (Hospital Morales Meseguer); M. Vice-
nte-Ruiz, C. Garcia-Zamora, A. Gonzalez-Gil, M. J.
Montoya-Tabares, M. Paredes-Quiles (Hospital Rafael
Mendez); J. Die Trill, P. Abadia, I. Moreno, J. D. Pina,
D. Ramos Rubio (Hospital Ramon y Cajal); J. Escartin,
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J. L. Blas, J. Fernando, R. Ferrer, J. Garcia Egea
(Hospital Royo Villanova); I. Pros, W. Martinez, J.
Rius, M. Socıas (Hospital Sant Joan de Deu de Mar-
torell); D. Sabia, J. Castellvi Valls, V. Gonzalez Santin,
S. Mompart Garcia, L. Viso Pons (Hospital Sant Joan
Despı Moises Broggi); D. Julia, A. Codina-Cazador, R.
Farres, N. Gomez, P. Planellas (Hospital Universitari de
Girona Doctor Josep Trueta); M. Cuadrado, I. Camps
(Hospital Universitari Germans Trias I Pujol); M.
Rufas, J. Escoll, A. Fermi~nan, P. Muriel, E. Sierra
(Hospital Universitario Arnau de Vilanova de Lerida);
C. Alvarez-Laso, P. Lora, H. Padin (Hospital Universi-
tario de Cabue~nes); J. Garcia-Septiem, C. Bustamante,
V. Jimenez, J. Jimenez-Miramon, J. L. Ramos (Hospital
Universitario de Getafe); A. B. Gallardo, P. Benito, L.
Colao, P. Galindo, C. Garcia (Hospital Universitario de
Torrejon de Ardoz); A. Forero-Torres, A. Alonso Poza,
B. Dieguez Fernandez, C. Gilsanz Martin, M. Hernan-
dez Garcia (Hospital Universitario del Sureste); J. A.
Rojo Lopez, J. M. Gil Lopez, M. Gonzalez Zunzarren,
J. Martınez Alegre, L. P. Zorrilla Matilla (Hospital
Universitario Infanta Sofia); A. Navarro-Sanchez, F. J.
Alcala Serrano, J. Lopez-Fernandez, D. Montesdeoca
Cabrera (Hospital Universitario Insular de Gran
Canaria); M. Alvarez-Gallego, J. Guevara, I. Pascual
Miguela~nez, I. Rubio-Perez (Hospital Universitario La
Paz); M. Gomez Ruiz, J. Alonso Martın, C. Cagigas
Fernandez, J. Castillo Diego (Hospital Universitario
Marques de Valdecilla); J. A. Pando, C. Maristany, A.
Mu~noz-Duyos, A. Rada-Palomino, H. Vargas-Pierola
(Hospital Universitario Mutua Terrassa); E. Pe~na Ros,
J. A. Benavides Buleje, J. M. Mu~noz Camarena, P. A.
Parra Ba~nos, M. Ramirez Faraco (Hospital Universitario
Reina Sofıa); J. J. Arenal, M. A. Citores, J. L. Marcos,
J. Sanchez, C. Tinoco (Hospital Universitario Rıo Hor-
tega); L. J. Garcıa Florez, R. D. Arias Pacheco, G.
Mınguez Ruiz, N. Gutierrez Corral, A. Rodrıguez
Infante (Hospital Universitario San Agustın); M. J. Car-
rillo Lopez, M. M. Carrasco Prats, A. Lage Laredo, A.
Martınez Manzano, P. Rodrıguez Garcıa (Hospital
Universitario Santa Lucia); J. J. Segura-Sampedro, N.
Alonso-Hernandez, M. Fernandez Isart, M. Gamundi
Cuesta, A. Ochogavia Segui (Hospital Universitario Son
Espases); N. Iba~nez, J. Abrisqueta, J. Lujan (Hospital
Universitario Virgen de la Arrixaca); R. Gomez Perez,
E. Corrales Valero, C. Monje Salazar, E. Sanchiz Carde-
nas, R. Soler Humanes (Hospital Universitario Virgen
de la Victoria); R. M. Jimenez-Rodriguez, F. De la Por-
tilla, J. M. Diaz Pavon, A. M. Garcia Cabrera, M. L.
Reyes Diaz (Hospital Universitario Virgen del Rocio);
E. Espin, F. Marinello, M. Martı, J. L. Sanchez, F. Vall-
ribera (Hospital Valle de Hebron); F. J. Orts Mico, M.
Ortin Navarro, M. Perez Climent, C. Serra Diaz
(Hospital Virgen de los Lirios); M. Millan, A. Caro, J.
Escuder, B. Espina, F. Feliu (Joan XXIII University
Hospital); A. Climent Aira, A. Estevez Diz, M. T. Mor-
eno Asencio, A. Varela Mato, R. Vazquez Bouzan
(POVISA Hospital); A. M. Minaya-Bravo, M.M. Diez-
Alonso, R. Villeta-Plaza (Principe de Asturias Hospital);
H. Guadalajara, D. Alıas, D. Garcıa Olmo, C. Pastor, I.
Valverde (Quironsalud Publicos); A. Sanchez Romero,
A. Gardea, M. Gil Santos, T. Nimmersgern, P. Serrano
Paz (Unidad de Coloproctorlogia, Hospital Vinalopo-
Torrevieja); M. Romero-Simo, T. Blasco-Segura, I. Car-
avaca-Garcıa, D. Costa-Navarro, A. Zarco-Pleguezuelos
(University General Hospital of Alicante); L. Sanchez-
Guillen, B. Flor-Lorente, M. Frasson, A. Garcıa-Gran-
ero, E. Garcıa-Granero (University Hospital La Fe
Valencia); B. Arencibia, J. Alonso, G. Febles, E. M.
Nogues, C. Roque (University Hospital of Gran
Canaria Dr. Negrın).
Sweden: J. Segelman, J. Nygren (Ersta Hospital); G.
Nestler (Falu lasarett); M. Abraham-Nordling, M.
Egenvall (Karolinska University Hospital); P. Myrelid,
B. Jung, P. Loftas (Link€oping University Hospital); M-
L. Lydrup, N. Azahr, P. Buchwald, P. Mangell, I. Syk
(Skane University Hospital); M. Nikberg, J. Carlander,
A. Chabok, K. Smedh, C. Tiselius (V€astmanlands
Hospital V€asteras); S. Haapaniemi, A. Benckert (Vrin-
nevi Hospital Norrkoping).
Switzerland: M. Adamina, C. Freil-Lanter, C. Gin-
gert, P. M€uller, J. Sch€afli (Kantonsspital Winterthur); L.
Regusci, M. Brenna, F. Fasolini (Regional Hospital
Mendrisio); H. Misteli, P. Kirchhoff, D. Oertli (Univer-
sity Hospital Basel, Switzerland); D. Hahnloser, D.
Clerc, M. H€ubner (University Hospital of Lausanne,
CHUV); F. Ris, N. C. Buchs, M. Chevallay, P. Morel,
B. Schiltz (University Hospitals Geneva).
Taiwan: J. Y. Wang, W-C. Su, C-W. Huang, C-J. Ma,
H-L. Tsai (KaohsiungMedical University Hospital).
Turkey: D. Bugra (American Hospital); F. Agalar, H.
Baloglu, I. Basoglu (Anadolu Medical Center [in aff with
Johns Hopkins Med]); N. Okkabaz, E. Binboga, A. Biri-
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Correction added on 30 October 2018, after first online
and print publication: the author A. D’Hoore was
added as a 2017 collaborator from University Hospital
Leuven.
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